Review
doi: 10.1016/S1470-2045(12)70137-7. Epub 2012 May 9. Global burden of cancers attributable to infections in 2008: a review and synthetic analysisAffiliations
AffiliationItem in Clipboard
Review
Global burden of cancers attributable to infections in 2008: a review and synthetic analysisCatherine de Martel et al. Lancet Oncol. 2012 Jun.
Free article doi: 10.1016/S1470-2045(12)70137-7. Epub 2012 May 9. AffiliationItem in Clipboard
AbstractBackground: Infections with certain viruses, bacteria, and parasites have been identified as strong risk factors for specific cancers. An update of their respective contribution to the global burden of cancer is warranted.
Methods: We considered infectious agents classified as carcinogenic to humans by the International Agency for Research on Cancer. We calculated their population attributable fraction worldwide and in eight geographical regions, using statistics on estimated cancer incidence in 2008. When associations were very strong, calculations were based on the prevalence of infection in cancer cases rather than in the general population. Estimates of infection prevalence and relative risk were extracted from published data.
Findings: Of the 12·7 million new cancer cases that occurred in 2008, the population attributable fraction (PAF) for infectious agents was 16·1%, meaning that around 2 million new cancer cases were attributable to infections. This fraction was higher in less developed countries (22·9%) than in more developed countries (7·4%), and varied from 3·3% in Australia and New Zealand to 32·7% in sub-Saharan Africa. Helicobacter pylori, hepatitis B and C viruses, and human papillomaviruses were responsible for 1·9 million cases, mainly gastric, liver, and cervix uteri cancers. In women, cervix uteri cancer accounted for about half of the infection-related burden of cancer; in men, liver and gastric cancers accounted for more than 80%. Around 30% of infection-attributable cases occur in people younger than 50 years.
Interpretation: Around 2 million cancer cases each year are caused by infectious agents. Application of existing public health methods for infection prevention, such as vaccination, safer injection practice, or antimicrobial treatments, could have a substantial effect on the future burden of cancer worldwide.
Funding: Fondation Innovations en Infectiologie (FINOVI) and the Bill & Melinda Gates Foundation (BMGF).
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articlesPlummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Plummer M, et al. Lancet Glob Health. 2016 Sep;4(9):e609-16. doi: 10.1016/S2214-109X(16)30143-7. Epub 2016 Jul 25. Lancet Glob Health. 2016. PMID: 27470177
Antonsson A, Wilson LF, Kendall BJ, Bain CJ, Whiteman DC, Neale RE. Antonsson A, et al. Aust N Z J Public Health. 2015 Oct;39(5):446-51. doi: 10.1111/1753-6405.12445. Aust N Z J Public Health. 2015. PMID: 26437730 Free PMC article.
Pisani P, Parkin DM, Muñoz N, Ferlay J. Pisani P, et al. Cancer Epidemiol Biomarkers Prev. 1997 Jun;6(6):387-400. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9184771 Review.
Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S. Forman D, et al. Vaccine. 2012 Nov 20;30 Suppl 5:F12-23. doi: 10.1016/j.vaccine.2012.07.055. Vaccine. 2012. PMID: 23199955 Review.
Parkin DM. Parkin DM. Int J Cancer. 2006 Jun 15;118(12):3030-44. doi: 10.1002/ijc.21731. Int J Cancer. 2006. PMID: 16404738
Morgan DR, Torres J, Sexton R, Herrero R, Salazar-Martínez E, Greenberg ER, Bravo LE, Dominguez RL, Ferreccio C, Lazcano-Ponce EC, Meza-Montenegro MM, Peña EM, Peña R, Correa P, Martínez ME, Chey WD, Valdivieso M, Anderson GL, Goodman GE, Crowley JJ, Baker LH. Morgan DR, et al. JAMA. 2013 Feb 13;309(6):578-86. doi: 10.1001/jama.2013.311. JAMA. 2013. PMID: 23403682 Free PMC article. Clinical Trial.
Bu GL, Xie C, Kang YF, Zeng MS, Sun C. Bu GL, et al. Viruses. 2022 Oct 27;14(11):2372. doi: 10.3390/v14112372. Viruses. 2022. PMID: 36366470 Free PMC article. Review.
Ogorodova LM, Fedorova OS, Sripa B, Mordvinov VA, Katokhin AV, Keiser J, Odermatt P, Brindley PJ, Mayboroda OA, Velavan TP, Freidin MB, Sazonov AE, Saltykova IV, Pakharukova MY, Kovshirina YV, Kaloulis K, Krylova OY, Yazdanbakhsh M; TOPIC Consortium. Ogorodova LM, et al. PLoS Negl Trop Dis. 2015 Apr 2;9(4):e0003563. doi: 10.1371/journal.pntd.0003563. eCollection 2015 Apr. PLoS Negl Trop Dis. 2015. PMID: 25836334 Free PMC article. No abstract available.
Lee HJ, Kim SR, Jung YJ, Han JA. Lee HJ, et al. Sci Rep. 2021 May 10;11(1):9853. doi: 10.1038/s41598-021-89220-5. Sci Rep. 2021. PMID: 33972599 Free PMC article.
Fayed B, Shakartalla SB, Sabbah H, Dalle H, Tannira M, Senok A, Soliman SSM. Fayed B, et al. Mycopathologia. 2024 Jul 11;189(4):65. doi: 10.1007/s11046-024-00868-9. Mycopathologia. 2024. PMID: 38990436
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3